Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry

Journal of Virological Methods

Volumn 131, Issue 2, 2006, Pages 134-142

  Brockman, Mark A ^a   Tanzi, Giancarlo O ^a   Walker, Bruce D ^a   Allen, Todd M ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Fitness; Flow cytometry; Green fluorescent protein; Human immunodeficiency virus

Indexed keywords

CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; GREEN FLUORESCENT PROTEIN;

ANIMAL CELL; ARTICLE; CELL LINE; CONTROLLED STUDY; DISEASE COURSE; FIBROBLAST; FLOW CYTOMETRY; FLUORESCENCE ACTIVATED CELL SORTING; HUMAN IMMUNODEFICIENCY VIRUS 1; MICROBIAL ACTIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; VIROGENESIS; VIRUS ISOLATION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

CELL LINE; FLOW CYTOMETRY; GENES, REPORTER; GREEN FLUORESCENT PROTEINS; HIV-1; HUMANS; RECEPTORS, CCR5; RECEPTORS, CXCR4; STAINING AND LABELING; T-LYMPHOCYTES; VIROLOGY; VIRUS REPLICATION;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 30644465555     PISSN: 01660934     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jviromet.2005.08.003     Document Type: Article

References (34)

1. A. Adachi, H.E. Gendelman, S. Koenig, T. Folks, R. Willey, A. Rabson, and M.A. Martin Production of acquired immunodeficiency syndrome-associated retrovirus in human and nonhuman cells transfected with an infectious molecular clone J. Virol. 59 2 1986 284 291
2. L. Alexander, E. Weiskopf, T.C. Greenough, N.C. Gaddis, M.R. Auerbach, M.H. Malim, S.J. O'Brien, B.D. Walker, J.L. Sullivan, and R.C. Desrosiers Unusual polymorphisms in human immunodeficiency virus type 1 associated with nonprogressive infection J. Virol. 74 9 2000 4361 4376
3. P. Ashorn, T.J. McQuade, S. Thaisrivongs, A.G. Tomasselli, W.G. Tarpley, and B. Moss An inhibitor of the protease blocks maturation of human and simian immunodeficiency viruses and spread of infection Proc. Natl. Acad. Sci. U.S.A. 87 19 1990 7472 7476
4. S.C. Ball, A. Abraha, K.R. Collins, A.J. Marozsan, H. Baird, M.E. Quinones-Mateu, A. Penn-Nicholson, M. Murray, N. Richard, M. Lobritz, P.A. Zimmerman, T. Kawamura, A. Blauvelt, and E.J. Arts Comparing the ex vivo fitness of CCR5-tropic human immunodeficiency virus type 1 isolates of subtypes B and C J. Virol. 77 2 2003 1021 1038
5. J.D. Barbour, T. Wrin, R.M. Grant, J.N. Martin, M.R. Segal, C.J. Petropoulos, and S.G. Deeks Evolution of phenotypic drug susceptibility and viral replication capacity during long-term virologic failure of protease inhibitor therapy in human immunodeficiency virus-infected adults J. Virol. 76 21 2002 11104 11112
6. M.T. Boyd, G.R. Simpson, A.J. Cann, M.A. Johnson, and R.A. Weiss A single amino acid substitution in the V1 loop of human immunodeficiency virus type 1 gp120 alters cellular tropism J. Virol. 67 6 1993 3649 3652
7. T.B. Campbell, K. Schneider, T. Wrin, C.J. Petropoulos, and E. Connick Relationship between in vitro human immunodeficiency virus type 1 replication rate and virus load in plasma J. Virol. 77 22 2003 12105 12112
8. D. Candotti, D. Costagliola, C. Joberty, O. Bonduelle, C. Rouzioux, B. Autran, and H. Agut Status of long-term asymptomatic HIV-1 infection correlates with viral load but not with virus replication properties and cell tropism. French ALT Study Group J. Med. Virol. 58 3 1999 256 263
9. A.J. Cann, J.A. Zack, A.S. Go, S.J. Arrigo, Y. Koyanagi, P.L. Green, S. Pang, and I.Y. Chen HIV-1 T-cell tropism is determined by events prior to provirus formation J. Virol. 64 1990 4735 4742
10. M. Carrington, and S.J. O'Brien The influence of HLA genotype on AIDS Annu. Rev. Med. 54 2003 535 551
11. T. Cilliers, J. Nhlapo, M. Coetzer, D. Orlovic, T. Ketas, W.C. Olson, J.P. Moore, A. Trkola, and L. Morris The CCR5 and CXCR4 coreceptors are both used by human immunodeficiency virus type 1 primary isolates from subtype C J. Virol. 77 7 2003 4449 4456
12. N. Dejucq HIV-1 replication in CD4+ T cell lines: the effects of adaptation on co-receptor use, tropism, and accessory gene function J. Leukoc. Biol. 68 3 2000 331 337
13. H. Deng, R. Liu, W. Ellmeier, S. Choe, D. Unutmaz, M. Burkhart, P. Di Marzio, S. Marmon, R.E. Sutton, C.M. Hill, C.B. Davis, S.C. Peiper, T.J. Schall, D.R. Littman, and N.R. Landau Identification of a major co-receptor for primary isolates of HIV-1 Nature 381 6584 1996 661 666
14. Y. Desfosses, M. Solis, Q. Sun, N. Grandvaux, C. Van Lint, A. Burny, A. Gatignol, M.A. Wainberg, R. Lin, and J. Hiscott Regulation of human immunodeficiency virus type 1 gene expression by clade-specific Tat proteins J. Virol. 79 14 2005 9180 9191
15. T.C. Friedrich, C.A. Frye, L.J. Yant, D.H. O'Connor, N.A. Kriewaldt, M. Benson, L. Vojnov, E.J. Dodds, C. Cullen, R. Rudersdorf, A.L. Hughes, N. Wilson, and D.I. Watkins Extraepitopic compensatory substitutions partially restore fitness to simian immunodeficiency virus variants that escape from an immunodominant cytotoxic-T-lymphocyte response J. Virol. 78 5 2004 2581 2585
16. A. Gervaix, D. West, L.M. Leoni, D.D. Richman, F. Wong-Staal, and J. Corbeil A new reporter cell line to monitor HIV infection and drug susceptibility in vitro Proc. Natl. Acad. Sci. U.S.A. 94 9 1997 4653 4658
17. S. Goldstein, C.R. Brown, H. Dehghani, J.D. Lifson, and V.M. Hirsch Intrinsic susceptibility of rhesus macaque peripheral CD4(+) T cells to simian immunodeficiency virus in vitro is predictive of in vivo viral replication J. Virol. 74 20 2000 9388 9395
18. M. Haltiner, T. Kempe, and R. Tijan A novel strategy for constructing clustered point mutations Nucleic Acids Res. 13 1985 1015 1025
19. F. Kirchhoff, T.C. Greenough, D.B. Brettler, J.L. Sullivan, and R.C. Desrosiers Brief report: absence of intact nef sequences in a long-term survivor with nonprogressive HIV-1 infection N. Engl. J. Med. 332 4 1995 228 232
20. Y. Koyanagi, S. Miles, R.T. Mitsuyasu, J.E. Merrrill, H.V. Vinters, and I.Y. Chen Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms Science 236 1987 819 822
21. A.J. Marozsan, D.M. Moore, M.A. Lobritz, E. Fraundorf, A. Abraha, J.D. Reeves, and E.J. Arts Differences in the fitness of two diverse wild-type human immunodeficiency virus type 1 isolates are related to the efficiency of cell binding and entry J. Virol. 79 11 2005 7121 7134
22. J.W. Mellors, C.R. Rinaldo Jr., P. Gupta, R.M. White, J.A. Todd, and L.A. Kingsley Prognosis in HIV-1 infection predicted by the quantity of virus in plasma Science 272 5265 1996 1167 1170
23. J.P. Morgenstern, and H. Land Advanced mammalian gene transfer: high titre retroviral vectors with multiple drug selection markers and a complementary helper-free packaging cell line Nucleic Acids Res. 18 12 1990 3587 3596
24. F.W. Peyerl, H.S. Bazick, M.H. Newberg, D.H. Barouch, J. Sodroski, and N.L. Letvin Fitness costs limit viral escape from cytotoxic T lymphocytes at a structurally constrained epitope J. Virol. 78 24 2004 13901 13910
25. T.C. Pierson, and R.W. Doms HIV-1 entry and its inhibition Curr. Top. Microbiol. Immunol. 281 2003 1 27
26. M.E. Quinones-Mateu, S.C. Ball, A.J. Marozsan, V.S. Torre, J.L. Albright, G. Vanham, G. van Der Groen, R.L. Colebunders, and E.J. Arts A dual infection/competition assay shows a correlation between ex vivo human immunodeficiency virus type 1 fitness and disease progression J. Virol. 74 19 2000 9222 9233
27. J.D. Reeves, S.A. Gallo, N. Ahmad, J.L. Miamidian, P.E. Harvey, M. Sharron, S. Pohlmann, J.N. Sfakianos, C.A. Derdeyn, R. Blumenthal, E. Hunter, and R.W. Doms Sensitivity of HIV-1 to entry inhibitors correlates with envelope/coreceptor affinity, receptor density, and fusion kinetics Proc. Natl. Acad. Sci. U.S.A. 99 25 2002 16249 16254
28. D.D. Richman, T. Wrin, S.J. Little, and C.J. Petropoulos Rapid evolution of the neutralizing antibody response to HIV type 1 infection Proc. Natl. Acad. Sci. U.S.A. 100 7 2003 4144 4149
29. M. Stevenson HIV-1 pathogenesis Nat. Med. 9 7 2003 853 860
30. R.M. Troyer, K.R. Collins, A. Abraha, E. Fraundorf, D.M. Moore, R.W. Krizan, Z. Toossi, R.L. Colebunders, M.A. Jensen, J.I. Mullins, G. Vanham, and E.J. Arts Changes in human immunodeficiency virus type 1 fitness and genetic diversity during disease progression J. Virol. 79 14 2005 9005 9018
31. A.B. van't Wont, H. Blaak, L.J. Ran, M. Brouwer, C. Kuiken, and H. Schuitemaker Evolution of syncytium-inducing and non-syncytium-inducing biological virus clones in relation to replication kinetics during the course of human immunodeficiency virus type 1 infection J. Virol. 72 6 1998 5099 5107
32. X. Wei, J.M. Decker, S. Wang, H. Hui, J.C. Kappes, X. Wu, J.F. Salazar-Gonzalez, M.G. Salazar, J.M. Kilby, M.S. Saag, N.L. Komarova, M.A. Nowak, B.H. Hahn, P.D. Kwong, and G.M. Shaw Antibody neutralization and escape by HIV-1 Nature 422 6929 2003 307 312
33. D.A. Wilkinson, E.A. Operskalski, M.P. Busch, J.W. Mosley, and R.A. Koup A 32-bp deletion within the CCR5 locus protects against transmission of parenterally acquired human immunodeficiency virus but does not affect progression to AIDS-defining illness J. Infect. Dis. 178 4 1998 1163 1166
34. H. Zhang, Y. Zhou, C. Alcock, T. Kiefer, D. Monie, J. Siliciano, Q. Li, P. Pham, J. Cofrancesco, D. Persaud, and R.F. Siliciano Novel single-cell-level phenotypic assay for residual drug susceptibility and reduced replication capacity of drug-resistant human immunodeficiency virus type 1 J. Virol. 78 4 2004 1718 1729